Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Wendy Mcdermott is SVP, Human Resources at Lexicon Pharmaceuticals. OQRO lists 9 transactions filed with the SEC under this name, the latest on Mar 3, 2026, each linked to the official Form 4.
SVP, Human Resources
Disclosures on record
9
Companies involved
1
Wendy Mcdermott bought shares on the open market in 2023, and has not bought since 2023.
Wendy Mcdermott reported 2 open-market purchases and 0 sales since 2023; purchases in 2023.
| Year | Bought | Sold |
|---|---|---|
| 2023 | $35K2×2 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Lexicon PharmaceuticalsLXRX
9 disclosures · Feb 2026 – Mar 2026
Feb 28, 202628Kdisclosed Mar 3
DetailsOfficial recordFeb 28, 202652Kdisclosed Mar 3
DetailsOfficial recordFeb 28, 2026144Kdisclosed Mar 3
DetailsOfficial recordFeb 28, 202628Kdisclosed Mar 3
DetailsOfficial recordFeb 28, 202652Kdisclosed Mar 3
DetailsOfficial recordFeb 28, 2026144Kdisclosed Mar 3
DetailsOfficial recordFeb 28, 202668Kdisclosed Mar 3
DetailsOfficial recordFeb 12, 2026375Kdisclosed Feb 17
DetailsOfficial recordFeb 12, 2026250Kdisclosed Feb 17
DetailsOfficial recordAs of the latest filing on , Wendy Mcdermott reported holding 277,945 shares of Lexicon Pharmaceuticals (LXRX), worth about $498K at the last close of $2 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Lexicon Pharmaceuticals LXRX | 277,945 | 278K direct | $2 | $498K | Feb 28, 2026 |
Is this Wendy Mcdermott’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Wendy Mcdermott reported 2 open-market purchases and 0 sales here, 2023.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Feb 28, 2026, Wendy Mcdermott reported holding 277,945 shares of Lexicon Pharmaceuticals (LXRX). At the last close of $2 on Nov 13, 2026, that is about $498K. This is the stake disclosed in filings, not a net worth.
Wendy Mcdermott bought shares on the open market in 2023, and has not bought since 2023.
In SEC filings since 2023: the latest open-market purchase is from 2023; no open-market sale is on record.
Lexicon Pharmaceuticals (LXRX), from 2023 to 2023: 2 purchases and 0 sales.
